|
Introduction
Ron Z. Goetzel
|
The Financial Impact of Health Promotion and Disease Prevention
Programs—Why Is It So Hard To Prove Value?
Ron Goetzel, editor of this special issue, reviews
the contents and context.
|
|
Methodology
David R. Anderson
Seth A. Serxner
Daniel B. Gold
|
Conceptual Framework, Critical Questions, and Practical Challenges in
Conducting Research on the Financial Impact of Worksite Health Promotion
A conceptual framework to
guide research on the financial impact of health promotion programs is
described. Important
questions that must be answered within this framework are discussed and
brief summaries of the research addressing these questions are summarized.
Key issues and challenges that are encountered in designing and
implementing financial outcome research are reviewed.
|
|
|
|
|
Ronald J. Ozminkowski
Ron Z. Goetzel
|
Getting Closer to the Truth: Overcoming
Research Challenges When Estimating The Financial Impact of Worksite
Health Promotion Programs
The authors describe the most
important methodological challenges often encountered in conducting
research and evaluation on the financial impact of health promotion.
These include selection bias, skewed data, small sample size,
metrics. They discuss when
these problems can and cannot be overcome and suggest how some of these
problems can be overcome through a creating an appropriate framework for
the study, and using state of the art statistical methods.
|
|
Reviews
Steven
G. Aldana
|
Financial
Impact of Health Promotion Programs:
A Comprehensive Review of the Literature
A
comprehensive review of the literature on the relationship between
lifestyle behaviors, health promotion programs and financial outcomes of
absenteeism and medical care costs was conducted to determine the
methodological quality of the literature, determine if costs are higher
for those with unhealthy lifestyles and if health promotion programs save
money. The search produced
196 studies, 74 of which meet the inclusion criteria.
Of the 34 correlational
studies 9 had multivariate controls of confounding variables. Of the 50 intervention studies, 4 had experimental designs,
24 had quasi-experimental designs and 22 had non-experimental designs.
There are good correlational data to suggest that high levels of
stress, excessive body weight, and multiple risk factors are associated
with increased health care costs and illness-related absenteeism.
The associations between seat belt use, cholesterol, diet,
hypertension, and alcohol abuse and absenteeism and health care
expenditures are either mixed or unknown.
Eighteen of 18 intervention studies found that absenteeism dropped after
the introduction of the health promotion program and the six studies which
reported cost benefit ratios averaged savings of $5.07 for every dollar
invested. Twenty eight of the
32 intervention studies found
that medical care costs dropped after the introduction of a health
promotion program and the 10 studies which reported cost benefit ratios
averaged savings of $3.93 for every dollar invested.
The overall quality of the literature is rated
"indicative" meaning that even though the relationship is
probably causal, a statement
of causality is premature until larger scale studies with randomized
control designs are completed.
|
|
|
|
|
Wendy Max
|
The Financial Impact of Smoking on Health Related Costs:
A Review of the Literature
A literature search was
conducted to determine the financial impact of smoking on health related
outcomes. The literature
cited in three recent prominent literature searches was supplemented with
searches of three literature databases to identify the most recent
literature and literature focusing on specific subgroups.
Forty-nine studies were reviewed.
Studies on the annual costs concluded that 6% to 14% of all direct
medical costs are attributed to smoking.
Studies on lifetime costs of smoking were less definitive and
contradictory, finding that smokers die early and have high annual medical
costs while they are alive. However,
because smokers die early, they use medical services for fewer years, draw
fewer dollars from pensions and Social Security; but also contribute
income taxes for fewer years. For
employers, greater annual health care use is well
documented for specific employers or groups and seems to account for
approximately 6% of medical care costs, but no national studies exist. The financial impact of second hand smoke is not included
in these estimates of direct costs and the indirect costs are probably two
to three greater than the direct costs.
|
|
|
|
|
Thomas Golaszewski
|
Shining Lights: Studies
That Have Most Influenced The Understanding of Health Promotion's
Financial Impact
A panel of experts was
assembled to identify and then rank the five to 10 highest quality studies
which have been published on the relationship between health risks, health
promotion programs and financial outcomes.
Twenty-three studies were identified.
Twelve studies were selected for review based on the both the
quality of research methodology and the authors efforts to present results
from a broad range of intervention areas and program settings.
The methodology, results and limitations of the 12 highest rated
are reported here.
|
|
Research Application
Dee W. Edington
|
Emerging Research: A View
from One Research Center
The Health Management
Research Center at the University of Michigan has assembled a database on
health risks, medical care costs, an in some cases, productivity measures
for over 2,000,000 individuals. For
employees of its corporate consortium members, the database contains seven
to eighteen years of data. Working
with this data, the research team has observed a number of emerging
trends. These trends
have been stable in this data set for a number of years, but some of them
are yet to be subjected to rigorous external peer review.
The trends are summarized below.
1) Annual participation rates
of 20% to 30% in Health Risk Appraisal are typical; over 10 years, 80%
participate at least once, 60% at least twice and 40% at least three
times. 2) Among the employers
in the data base, excess risk factors account for 21% to 31% of medical
care costs, with a mean of 25%. 3) Medical care costs increase as the
number risk factors and age increase.
As risk factors increase, medical costs increase;
as risk factors decrease, medical care costs decrease. The mean cost increase per risk factor increased ($350) may
be more than double the mean cost decrease per risk factor decreased
($150). 4) Cost savings
greatest among those who participate in programs multiple times.
5) Absenteeism seems to be higher and other measures of
productivity lower for those with health risk factors.
6) Programs designed to keep healthy people healthy in addition to
reducing the risks of those with multiple risks will probably provide the
greatest return to the employers. 7) Best results may be achieved by
focusing efforts on employees who have clusters of risk factors associated
with low perceived health status. 8)
A corporate wellness score which combines risk factor levels and
participation rates may provide a "corporate wellness score"
which can be used to compare health status across employer.
9) Increased use of longitudinal data sets, fuzzy cut points for
data categories and data mining techniques may allow breakthroughs in
future analysis efforts.
|
|
|
|
|
Jeffrey R. Harris
Helen H. Schauffler
Arnold Milstein
Patricia Powers
David P. Hopkins
|
Expanding Health Insurance Coverage for Smoking Cessation Treatments:
Experience of the Pacific Business Group on Health
Despite strong consensus on
the behavioral and cost effectiveness of smoking cessation treatments,
most employer sponsored health insurance plans do not cover clinical
treatments for smoking cessation. The
Pacific Business Group on Health is a consortium of large employers in
California and the western United States which negotiates health coverage
for these employers. The
business case used to decide to expand its coverage for smoking cessation.
|
|
|
|
|
Perspectives
Ron Z. Goetzel
|
Corporate
Perspectives
Managers in 10 corporate settings reflect on what
matters to them and their top management in determining if health
promotion is a good investment for their organization.
Introduction:
A Corporate Perspective: Reflections From the Economic Buyer of Health
Promotion Programs
|
|
Gregg M. Stave
|
The Glaxo
Wellcome Health Promotion Program: The Contract for Health and Wellness
|
|
Vincent E. Kerr
|
Prevention:
Is There Value for Corporate Purchasers [General Electric]
|
|
Lawrence G. Shoner
Laura Cioffi
|
A Corporate
Perspective from Lucent Technologies: Reflections From the Economic Buyer
of Health Promotion Programs—What Really Matters to Me and My Boss?
|
|
Catherine Baase
|
An Optimistic
View From the Corporate Perspective [Dow Chemical]
|
|
Firky Isaac
P. Flynn
|
Johnson &
Johnson Live for Life Program: Now and Then
|
|
D’Ann Whitehead
|
A Corporate
Perspective on Health Promotion: Reflections and Advice From Chevron
|
|
Mary Schmitz
|
When the
Health Promotion Program Does Not Adapt to Changing Business Priorities:
The Experience at Southern California Edison
|
|
|
|
|
Michael A. Anderson
John A. Stoltzfus
|
The 3M Corporate Experience: Health As a Business Strategy
|
|
|
|
|
Molly J. McCauley
|
An Overview of Two
Worksite Health Promotion Programs—The Quest for Qualitative and
Quantitative Results: What Really Matters?
|
|
|
|
|
Judy Webster
|
Strategy, Not Return
on Investment, Drives Health Promotion at Applied Materials, Inc.
|
|
|
|
|
|
Federal
Government Perspectives
Officials from two government agencies reflect on
their agencies policies related to investment in health promotion
|
|
|
|
|
Jeffrey R. Harris
Priscilla B. Holman
Vilma G. Carande-Kulis
|
Financial Impact of Health Promotion: We Need To Know Much More, but We
Know Enough To Act
|
|
|
|
|
Catherine G. Gordon
Pauline J. Lapin
|
A Government
Perspective: If There Is So Much Proof, Why Is Medicare Not Rapidly
Adopting Health Promotion and Disease Prevention Programs?
|
|
|
|
|
|
Policy
Perspectives
Policy experts from a foundation
setting and an academic setting reflect on the apparent discrepancy
between our knowledge of the impact of health promotion and its limited
application.
|
|
|
|
|
Lester Breslow
|
Why Health Promotion
Lags Knowledge About Healthful Behavior
|
|
|
|
|
J. Michael McGinnis
|
Does Proof Matter? Why
Strong Evidence Sometimes Yields Weak Action
|